| Name | OnKure Therapeutics, Inc. |
|---|---|
| CIK | 0001637715 |
| Tickers | OKUR |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 472309515 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (720) 307-2892 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
406 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-001621 | 005-92480 | 261580227 | 34 | 35075 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-003184 | 005-92480 | 261561364 | 34 | 25354 | |||
| 2026-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-447247 | 001-40315 | 261522265 | 34 | 406998 | 1 | 1 |
| 2026-11-04 | 10-Q | 10-Q | 0001193125-26-447202 | 001-40315 | 261522079 | 34 | 9476507 | 1 | 1 | |
| 2026-10-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-114447 | 005-92480 | 261448039 | 34 | 25306 | |||
| 2026-09-23 | 4 | xslF345X06/form4-09232026_080903.xml | 0001609284-26-000005 | 5911 | ||||||
| 2026-09-23 | 4 | xslF345X06/form4-09232026_080937.xml | 0001692747-26-000005 | 5910 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097335 | 005-92480 | 261283428 | 34 | 13784 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002177 | 005-92480 | 261281914 | 34 | 25009 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-038382 | 005-92480 | 261281868 | 34 | 11964 | |||
| 2026-08-13 | 4/A | xslF345X06/form4a-08132026_080853.xml | 0001622769-26-000006 | 5558 | ||||||
| 2026-08-13 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-347315 | 001-40315 | 261269184 | 34 | 158454 | 1 | 1 |
| 2026-08-11 | 4 | 4 | 0001193125-26-344874 | 5497 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080842.xml | 0001547100-26-000005 | 5786 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080848.xml | 0001921956-26-000003 | 5804 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080858.xml | 0001622769-26-000002 | 11801 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080824.xml | 0001889716-26-000002 | 5807 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080811.xml | 0001240122-26-000006 | 5782 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080808.xml | 0001644467-26-000002 | 5760 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080840.xml | 0001609284-26-000004 | 29642 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080837.xml | 0001692747-26-000004 | 20922 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080827.xml | 0002037442-26-000002 | 11799 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080820.xml | 0001748961-26-000002 | 16407 | ||||||
| 2026-08-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001617201-26-000003 | 005-92480 | 261256417 | 34 | 15454 | |||
| 2026-08-04 | 424B5 | 424B5 | 0001193125-26-332839 | 333-291334 | 261238892 | 33 | 29440 | |||
| 2026-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-332809 | 001-40315 | 261238723 | 34 | 400257 | 1 | 1 |
| 2026-08-04 | 10-Q | 10-Q | 0001193125-26-332773 | 001-40315 | 261238546 | 34 | 8364893 | 1 | 1 | |
| 2026-06-24 | 4 | xslF345X06/form4-06242026_110612.xml | 0001609284-26-000003 | 6091 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_110637.xml | 0001692747-26-000003 | 6090 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-262279 | 5494 | ||||||
| 2026-06-08 | 4 | xslF345X06/form4-06082026_100623.xml | 0001547100-26-000004 | 5783 | ||||||
| 2026-06-08 | 4 | xslF345X06/form4-06082026_100605.xml | 0001921956-26-000002 | 5801 | ||||||
| 2026-06-08 | 4 | xslF345X06/form4-06082026_100613.xml | 0001889716-26-000001 | 5804 | ||||||
| 2026-06-08 | 4 | xslF345X06/form4-06082026_100628.xml | 0001240122-26-000003 | 5779 | ||||||
| 2026-06-08 | 4 | xslF345X06/form4-06082026_100629.xml | 0001644467-26-000001 | 5757 | ||||||
| 2026-06-05 | S-8 | S-8 | 0001193125-26-259599 | 333-296544 | 261069268 | 33 | 478224 | 1 | 1 | |
| 2026-06-04 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-257423 | 001-40315 | 261065151 | 34 | 456111 | 1 | 1 |
| 2026-05-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-001486 | 005-92480 | 261026833 | 34 | 39690 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062876 | 005-92480 | 26990444 | 34 | 13480 | |||
| 2026-05-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-206396 | 001-40315 | 26943158 | 34 | 361106 | 1 | 1 |
| 2026-05-05 | 10-Q | 10-Q | 0001193125-26-206345 | 001-40315 | 26942962 | 34 | 6948003 | 1 | 1 | |
| 2026-05-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001477 | 333-295304 | 26940141 | 33 | 1843 | ||
| 2026-04-30 | CORRESP | filename1.htm | 0001193125-26-197156 | 9436 | ||||||
| 2026-04-30 | UPLOAD | filename1.pdf | 0000000000-26-004422 | 333-295304 | 149225 | |||||
| 2026-04-24 | S-3 | S-3 | 0001193125-26-177093 | 333-295304 | 26893508 | 33 | 1201926 | 1 | 1 | |
| 2026-04-21 | DEFA14A | DEFA14A | 0001140361-26-015904 | 001-40315 | 26879641 | 34 | 2106677 | |||
| 2026-04-21 | DEF 14A | DEF 14A | 0001140361-26-015903 | 001-40315 | 26879624 | 34 | 5039376 | 1 | 1 | |
| 2026-04-21 | ARS | ARS | 0001193125-26-166821 | 001-40315 | 26879594 | 34 | 1401070 | |||
| 2026-04-07 | 3 | 3 | 0001193125-26-146027 | 28501 | ||||||
| 2026-04-07 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-146025 | 005-92480 | 26846276 | 34 | 286486 | |||
| 2026-04-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-145912 | 005-92480 | 26846115 | 34 | 298001 | |||
| 2026-04-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-015540 | 005-92480 | 26845336 | 34 | 24914 | |||
| 2026-04-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000096 | 005-92480 | 26845072 | 34 | 20023 | |||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_070404.xml | 0001609284-26-000002 | 5745 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_070438.xml | 0001692747-26-000002 | 5743 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_070422.xml | 0002037442-26-000001 | 5731 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_070420.xml | 0001748961-26-000001 | 5685 | ||||||
| 2026-04-01 | 4 | xslF345X06/form4-04012026_090435.xml | 0001547100-26-000003 | 5726 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_090406.xml | 0001547100-26-000002 | 8835 | ||||||
| 2026-04-01 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001636587-26-000021 | 005-92480 | 26825742 | 34 | 14706 | |||
| 2026-03-30 | 8-K | 8-K | 1.01,3.02,5.02,8.01,9.01 | 0001193125-26-130283 | 001-40315 | 26809751 | 34 | 633313 | 1 | 1 |
| 2026-03-24 | 4 | xslF345X06/form4-03242026_100353.xml | 0001609284-26-000001 | 5911 | ||||||
| 2026-03-24 | 4 | xslF345X06/form4-03242026_100303.xml | 0001692747-26-000001 | 5911 | ||||||
| 2026-03-12 | S-8 | S-8 | 0001193125-26-104215 | 333-294248 | 26748101 | 33 | 365340 | 1 | 1 | |
| 2026-03-12 | 10-K | 10-K | 0001193125-26-104147 | 001-40315 | 26747791 | 34 | 12444607 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-104104 | 001-40315 | 26747623 | 34 | 367558 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-016660 | 005-92480 | 26644800 | 34 | 19283 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-016541 | 005-92480 | 26643056 | 34 | 18329 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001088 | 005-92480 | 26641237 | 34 | 9302 | |||
| 2026-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000240 | 005-92480 | 26582428 | 34 | 7156 | |||
| 2026-01-02 | 4 | 4 | 0001193125-26-000942 | 4824 | ||||||
| 2026-01-02 | 4 | xslF345X05/form4-01022026_090120.xml | 0001622769-26-000001 | 5101 | ||||||
| 2025-12-23 | 4 | xslF345X05/form4-12242025_011243.xml | 0001609284-25-000004 | 5962 | ||||||
| 2025-12-23 | 4 | xslF345X05/form4-12242025_011233.xml | 0001692747-25-000004 | 5940 | ||||||
| 2025-11-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-116660 | 005-92480 | 251532420 | 34 | 36256 | |||
| 2025-11-21 | 424B3 | 424B3 | 0001193125-25-291362 | 333-282792 | 251508012 | 33 | 223889 | |||
| 2025-11-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003308 | 333-282792 | 251496550 | 33 | 1857 | ||
| 2025-11-06 | POS AM | POS AM | 0001193125-25-270150 | 333-282792 | 251459676 | 33 | 292312 | |||
| 2025-11-06 | S-3 | S-3 | 0001193125-25-270073 | 333-291334 | 251459492 | 33 | 1211150 | 1 | 1 | |
| 2025-11-06 | 424B3 | 424B3 | 0001193125-25-269724 | 333-282792 | 251458930 | 33 | 3214187 | |||
| 2025-11-06 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-269652 | 001-40315 | 251458728 | 34 | 684789 | 1 | 1 |
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269540 | 001-40315 | 251458421 | 34 | 8058467 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-269468 | 001-40315 | 251458198 | 34 | 397196 | 1 | 1 |
| 2025-10-02 | 4 | 4 | 0001193125-25-228402 | 4828 | ||||||
| 2025-10-02 | 4 | xslF345X05/form4-10022025_081020.xml | 0001622769-25-000003 | 5102 | ||||||
| 2025-09-24 | 4 | xslF345X05/form4-09242025_110912.xml | 0001609284-25-000003 | 5774 | ||||||
| 2025-09-24 | 4 | xslF345X05/form4-09242025_110914.xml | 0001692747-25-000003 | 5774 | ||||||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021974 | 005-92480 | 251221220 | 34 | 11315 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-109073 | 005-92480 | 251221084 | 34 | 9925 | |||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003640 | 005-92480 | 251219002 | 34 | 9105 | |||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-076638 | 005-92480 | 251218714 | 34 | 26036 | |||
| 2025-08-12 | 10-Q | 10-Q | 0001193125-25-178981 | 001-40315 | 251207034 | 34 | 7940424 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-178978 | 001-40315 | 251207029 | 34 | 394154 | 1 | 1 |
| 2025-08-12 | 424B3 | 424B3 | 0001193125-25-178979 | 333-282792 | 251207025 | 33 | 2646465 | |||
| 2025-07-02 | 4 | 4 | 0000950170-25-093063 | 4840 | ||||||
| 2025-07-02 | 4 | xslF345X05/form4-07022025_080710.xml | 0001415889-25-019052 | 5101 | ||||||
| 2025-06-26 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-090403 | 001-40315 | 251080545 | 34 | 9830212 | 1 | 1 |
| 2025-06-25 | 4 | xslF345X05/form4-06252025_100613.xml | 0001415889-25-018235 | 5773 | ||||||
| 2025-06-25 | 4 | xslF345X05/form4-06252025_100636.xml | 0001415889-25-018234 | 5773 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079841 | 5373 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_080528.xml | 0001415889-25-015019 | 5664 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_080518.xml | 0001415889-25-015018 | 5640 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_080515.xml | 0001415889-25-015016 | 5667 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_080510.xml | 0001415889-25-015015 | 10662 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_080501.xml | 0001415889-25-015014 | 5620 | ||||||
| 2025-05-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001636587-25-000030 | 005-92480 | 251010628 | 34 | 150550 | |||
| 2025-05-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001723643-25-000011 | 005-92480 | 251004003 | 34 | 11799 | 1 | 1 | |
| 2025-05-28 | 424B3 | 424B3 | 0000950170-25-078388 | 333-282792 | 25995902 | 33 | 92910 | |||
| 2025-05-28 | 8-K | 8-K | 5.07,9.01 | 0000950170-25-078375 | 001-40315 | 25995794 | 34 | 173476 | 1 | 1 |
| 2025-05-27 | 3 | 3 | 0000950170-25-078004 | 6285 | ||||||
| 2025-05-22 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001636587-25-000027 | 005-92480 | 25977937 | 34 | 150259 | |||
| 2025-05-19 | 4 | xslF345X05/form4.xml | 0000929638-25-001950 | 14417 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074459 | 10797 | ||||||
| 2025-05-19 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002418 | 005-92480 | 25963494 | 34 | 10356 | |||
| 2025-05-14 | 4 | xslF345X05/form4.xml | 0000929638-25-001870 | 14541 | ||||||
| 2025-05-06 | 424B3 | 424B3 | 0000950170-25-063972 | 333-282792 | 25915279 | 33 | 2381496 | |||
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-063970 | 001-40315 | 25915270 | 34 | 7246042 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063969 | 001-40315 | 25915260 | 34 | 406853 | 1 | 1 |
| 2025-04-16 | DEFA14A | DEFA14A | 0001140361-25-014186 | 001-40315 | 25843128 | 34 | 3929461 | |||
| 2025-04-16 | DEF 14A | DEF 14A | 0001140361-25-014183 | 001-40315 | 25843085 | 34 | 4268813 | 1 | 1 | |
| 2025-04-16 | ARS | ARS | 0000950170-25-054752 | 001-40315 | 25843059 | 34 | 1673334 | |||
| 2025-04-08 | 4 | xslF345X05/form4-04082025_090410.xml | 0001415889-25-010419 | 7807 | ||||||
| 2025-04-08 | 4 | xslF345X05/form4-04082025_090445.xml | 0001415889-25-010418 | 7809 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-049473 | 4839 | ||||||
| 2025-04-02 | 4 | xslF345X05/form4-04022025_080441.xml | 0001415889-25-009659 | 5100 | ||||||
| 2025-03-24 | 424B3 | 424B3 | 0001193125-25-061340 | 333-282792 | 25764174 | 33 | 3142332 | |||
| 2025-03-21 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000731 | 333-282792 | 25762109 | 33 | 1856 | ||
| 2025-03-20 | POS AM | POS AM | 0001193125-25-058954 | 333-282792 | 25756367 | 33 | 9874508 | 1 | 1 | |
| 2025-03-10 | S-8 | S-8 | 0000950170-25-036363 | 333-285680 | 25724218 | 33 | 207528 | |||
| 2025-03-10 | 424B3 | 424B3 | 0000950170-25-036341 | 333-282792 | 25724071 | 33 | 8128236 | |||
| 2025-03-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-036306 | 001-40315 | 25723866 | 34 | 391713 | 1 | 1 |
| 2025-03-10 | 10-K | 10-K | 0000950170-25-036252 | 001-40315 | 25723670 | 34 | 18920824 | 1 | 1 | |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-000885 | 005-92480 | 25623568 | 34 | 11483 | |||
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000772 | 005-92480 | 25601932 | 34 | 9291 | |||
| 2025-02-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-003306 | 005-92480 | 25598990 | 34 | 10405 | |||
| 2025-01-31 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000246 | 005-92480 | 25576353 | 34 | 6230 | |||
| 2025-01-29 | 4 | xslF345X05/form4-01302025_010119.xml | 0001415889-25-002312 | 5621 | ||||||
| 2025-01-29 | 4 | xslF345X05/form4-01302025_010107.xml | 0001415889-25-002311 | 5616 | ||||||
| 2025-01-29 | 4 | xslF345X05/form4-01302025_010153.xml | 0001415889-25-002310 | 5604 | ||||||
| 2025-01-29 | 4 | xslF345X05/form4-01302025_010108.xml | 0001415889-25-002309 | 5558 | ||||||
| 2025-01-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-004963 | 005-92480 | 25543573 | 34 | 29550 | |||
| 2024-12-10 | 424B3 | 424B3 | 0000950170-24-134758 | 333-282792 | 241537122 | 33 | 12643849 | |||
| 2024-12-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-134757 | 001-40315 | 241537121 | 34 | 10718832 | 1 | 1 |
| 2024-12-09 | S-8 | S-8 | 0000950170-24-134582 | 333-283693 | 241535494 | 33 | 317555 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-019110 | 005-92480 | 241461364 | 34 | 104584 | |||
| 2024-11-14 | SC 13G | ONKURE THERAPEUTICS, INC. | 0000902664-24-006543 | 005-92480 | 241458128 | 34 | 49023 | |||
| 2024-11-07 | 424B3 | 424B3 | 0000950170-24-123367 | 333-282792 | 241435949 | 33 | 3301226 | |||
| 2024-11-07 | 8-K | 8-K | 4.01,8.01,9.01 | 0000950170-24-123265 | 001-40315 | 241435489 | 34 | 1746999 | 1 | 1 |
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123233 | 001-40315 | 241435337 | 34 | 6645694 | 1 | 1 | |
| 2024-10-31 | 424B3 | 424B3 | 0001193125-24-248666 | 333-282792 | 241415274 | 33 | 4641839 | |||
| 2024-10-30 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-10-30 16:30:00 | 9999999995-24-003323 | 333-282792 | 241412151 | 33 | 1851 | ||
| 2024-10-28 | CORRESP | filename1.htm | 0001193125-24-245562 | 6656 | ||||||
| 2024-10-28 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-017999 | 005-92480 | 241400853 | 34 | 69615 | |||
| 2024-10-25 | UPLOAD | filename1.pdf | 0000000000-24-011951 | 333-282792 | 40161 | |||||
| 2024-10-23 | S-1 | S-1 | 0001193125-24-241926 | 333-282792 | 241389745 | 33 | 17959118 | 1 | 1 | |
| 2024-10-23 | SC 13G/A | deeptrack-okur100424a1.htm | 0001172661-24-004335 | 005-92480 | 241389404 | 34 | 103842 | |||
| 2024-10-21 | D | xslFormDX01/primary_doc.xml | 06b | 0001748961-24-000002 | 021-527340 | 241383009 | 33 | 16406 | ||
| 2024-10-16 | SC 13G/A | sc13g.htm | 0000929638-24-003523 | 005-92480 | 241374969 | 34 | 191940 | |||
| 2024-10-15 | 3 | xslF345X02/form3.xml | 0000929638-24-003520 | 13889 | ||||||
| 2024-10-11 | SC 13G | SC 13G | 0001104659-24-108113 | 005-92480 | 241368280 | 34 | 149481 | |||
| 2024-10-11 | SC 13G | sc13g.htm | 0000929638-24-003493 | 005-92480 | 241367806 | 34 | 220170 | |||
| 2024-10-11 | SC 13G | SC 13G | 0001104659-24-108050 | 005-92480 | 241367726 | 34 | 93306 | |||
| 2024-10-11 | SC 13G | deeptrack-okur100424.htm | 0001172661-24-004242 | 005-92480 | 241367514 | 34 | 103203 | |||
| 2024-10-10 | SC 13G | SC 13G | 0001193125-24-236085 | 005-92480 | 241366070 | 34 | 64100 | |||
| 2024-10-10 | SC 13D/A | SC 13D/A | 0001193125-24-235952 | 005-92480 | 241365556 | 34 | 203094 | |||
| 2024-10-09 | 3 | 3 | 0000950170-24-113744 | 7800 | ||||||
| 2024-10-09 | SC 13G | SC 13G | 0001193125-24-235212 | 005-92480 | 241362797 | 34 | 79263 | |||
| 2024-10-09 | SC 13G/A | bml13g.htm | 0001373604-24-000102 | 005-92480 | 241361944 | 34 | 75340 | |||
| 2024-10-09 | 4 | xslF345X05/form4.xml | 0001373604-24-000100 | 8351 | ||||||
| 2024-10-08 | SC 13D/A | NEW ENTERPRISE ASSOCIATES 15, L.P. / ONKURE THERAPEUTICS, INC. -- SCHEDULE 13D/A | 0001072613-24-000769 | 005-92480 | 241361265 | 34 | 116938 | |||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111041.xml | 0001415889-24-024921 | 19331 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111029.xml | 0001415889-24-024920 | 5599 | ||||||
| 2024-10-08 | 4 | 4 | 0000950170-24-113604 | 5308 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111032.xml | 0001415889-24-024919 | 5575 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111036.xml | 0001415889-24-024918 | 14919 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111035.xml | 0001415889-24-024917 | 5602 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111042.xml | 0001415889-24-024914 | 5657 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111039.xml | 0001415889-24-024913 | 5556 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111033.xml | 0001415889-24-024912 | 16058 | ||||||
| 2024-10-08 | 4 | xslF345X05/form4-10082024_111019.xml | 0001415889-24-024911 | 9677 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111024.xml | 0001415889-24-024910 | 8488 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111046.xml | 0001415889-24-024909 | 8471 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111047.xml | 0001415889-24-024908 | 8439 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111044.xml | 0001415889-24-024907 | 8478 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111049.xml | 0001415889-24-024906 | 8478 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111004.xml | 0001415889-24-024905 | 8464 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111048.xml | 0001415889-24-024904 | 8439 | ||||||
| 2024-10-08 | 3 | xslF345X02/form3-10082024_111007.xml | 0001415889-24-024903 | 8420 | ||||||
| 2024-10-08 | 8-K | 8-K | 2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01 | 0001193125-24-234487 | 001-40315 | 241361006 | 34 | 3148509 | 1 | 1 |
| 2024-10-02 | 425 | 425 | 0001193125-24-231283 | 001-40315 | 241348874 | 34 | 36440 | |||
| 2024-10-02 | 8-K | 8-K | 5.07 | 0001193125-24-231281 | 001-40315 | 241348836 | 34 | 173775 | 1 | 1 |
| 2024-09-26 | SC 13G | r925240sc13g.htm | 0001214659-24-016774 | 005-92480 | 241328778 | 34 | 112375 | |||
| 2024-09-26 | 4 | xslF345X05/form4.xml | 0001373604-24-000098 | 7817 | ||||||
| 2024-09-20 | 425 | 425 | 0001193125-24-222435 | 001-40315 | 241311668 | 34 | 90864 | |||
| 2024-09-20 | 8-K | 8-K | 8.01 | 0001193125-24-222429 | 001-40315 | 241311664 | 34 | 252714 | 1 | 1 |
| 2024-09-19 | 4 | xslF345X05/form4.xml | 0001373604-24-000094 | 7810 | ||||||
| 2024-09-16 | 4 | xslF345X05/form4.xml | 0001373604-24-000090 | 9726 | ||||||
| 2024-09-13 | 8-K | 8-K | 5.02 | 0001193125-24-218879 | 001-40315 | 241298031 | 34 | 148431 | 1 | 1 |
| 2024-08-26 | EFFECT | xslEFFECTX01/primary_doc.xml | S-4,,2024-08-26 16:30:00 | 9999999995-24-002630 | 333-280369 | 241243102 | 33 | 1771 | ||
| 2024-08-26 | 424B3 | 424B3 | 0001193125-24-207172 | 333-280369 | 241242238 | 33 | 8022767 | |||
| 2024-08-26 | S-4/A | S-4/A | 0001193125-24-206641 | 333-280369 | 241237704 | 33 | 8121562 | |||
| 2024-08-23 | CORRESP | filename1.htm | 0001193125-24-206283 | 8595 | ||||||
| 2024-08-19 | CORRESP | filename1.htm | 0001193125-24-202441 | 17767 | ||||||
| 2024-08-19 | S-4/A | S-4/A | 0001193125-24-202432 | 333-280369 | 241218188 | 33 | 8367058 | |||
| 2024-08-14 | 4 | xslF345X05/form4.xml | 0001373604-24-000071 | 7847 | ||||||
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-096411 | 001-40315 | 241202743 | 34 | 6493648 | 1 | 1 | |
| 2024-08-13 | 425 | 425 | 0000950170-24-096146 | 001-40315 | 241201285 | 34 | 342891 | |||
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-096127 | 001-40315 | 241201176 | 34 | 495950 | 1 | 1 |
| 2024-08-12 | UPLOAD | filename1.pdf | 0000000000-24-009213 | 333-280369 | 63842 | |||||
| 2024-07-29 | S-4/A | S-4/A | 0001193125-24-186500 | 333-280369 | 241148627 | 33 | 7791602 | |||
| 2024-07-26 | CORRESP | filename1.htm | 0001193125-24-186501 | 65031 | ||||||
| 2024-07-18 | UPLOAD | filename1.pdf | 0000000000-24-008170 | 333-280369 | 81670 | |||||
| 2024-06-21 | S-4 | S-4 | 0001193125-24-164731 | 333-280369 | 241057843 | 33 | 7265945 | |||
| 2024-05-21 | SC 13G/A | bml13g.htm | 0001373604-24-000032 | 005-92480 | 24967352 | 34 | 77981 | |||
| 2024-05-16 | 4 | xslF345X05/form4.xml | 0001373604-24-000028 | 7837 | ||||||
| 2024-05-16 | 3 | xslF345X02/form3.xml | 0001373604-24-000026 | 4769 | ||||||
| 2024-05-13 | 425 | 425 | 0001193125-24-136811 | 001-40315 | 24937215 | 34 | 13466900 | |||
| 2024-05-13 | 8-K | 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | 0001193125-24-136785 | 001-40315 | 24937137 | 34 | 14131956 | 1 | 1 |
| 2024-05-08 | SC 13D/A | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMA -- SCHEDULE 13D/A(#1) | 0001072613-24-000437 | 005-92480 | 24926771 | 34 | 315756 | |||
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-054452 | 001-40315 | 24921703 | 34 | 5915770 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-054442 | 001-40315 | 24921615 | 34 | 405370 | 1 | 1 |
| 2024-04-26 | 10-K/A | 10-K/A | 0000950170-24-048631 | 001-40315 | 24878452 | 34 | 1032187 | 1 | 1 | |
| 2024-03-28 | S-8 | S-8 | 0000950170-24-038022 | 333-278315 | 24798817 | 33 | 185237 | |||
| 2024-03-28 | 10-K | 10-K | 0000950170-24-038009 | 001-40315 | 24798690 | 34 | 8324833 | 1 | 1 | |
| 2024-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-038003 | 001-40315 | 24798650 | 34 | 422619 | 1 | 1 |
| 2024-02-23 | 8-K | 8-K | 2.05 | 0000950170-24-019338 | 001-40315 | 24670997 | 34 | 171228 | 1 | 1 |
| 2024-02-05 | SC 13G | j15240sc13g.htm | 0001214659-24-001920 | 005-92480 | 24595638 | 34 | 66900 | |||
| 2024-01-17 | SC 13G | bml13g.htm | 0001616824-24-000011 | 005-92480 | 24536269 | 34 | 78143 | |||
| 2023-12-26 | SC 13D | o1226230sc13d.htm | 0001214659-23-016861 | 005-92480 | 231513876 | 34 | 118080 | |||
| 2023-12-15 | SC 13D/A | SC 13D/A | 0001193125-23-296752 | 005-92480 | 231491121 | 34 | 67929 | |||
| 2023-12-14 | 8-K | 8-K | 2.05,8.01 | 0001193125-23-295039 | 001-40315 | 231485784 | 34 | 153566 | 1 | 1 |
| 2023-11-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-21 16:30:00 | 9999999995-23-003413 | 333-275518 | 231429869 | 33 | 1722 | ||
| 2023-11-17 | CORRESP | filename1.htm | 0001193125-23-279781 | 6324 | ||||||
| 2023-11-16 | UPLOAD | filename1.pdf | 0000000000-23-012582 | 40302 | ||||||
| 2023-11-13 | S-3 | S-3 | 0001193125-23-276182 | 333-275518 | 231399958 | 33 | 963252 | |||
| 2023-11-13 | 424B5 | 424B5 | 0001193125-23-276153 | 333-264616 | 231399791 | 33 | 503331 | |||
| 2023-11-13 | 10-Q | 10-Q | 0000950170-23-062910 | 001-40315 | 231398588 | 34 | 8207989 | 1 | 1 | |
| 2023-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-062888 | 001-40315 | 231398369 | 34 | 537343 | 1 | 1 |
| 2023-10-30 | 8-K | 8-K | 8.01 | 0000950170-23-056416 | 001-40315 | 231360949 | 34 | 175661 | 1 | 1 |
| 2023-10-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-252984 | 001-40315 | 231315429 | 34 | 15892062 | 1 | 1 |
| 2023-08-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-047626 | 9344 | ||||||
| 2023-08-28 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000714 | 001-40315 | 231217364 | 33 | 4158 | |||
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041302 | 001-40315 | 231159319 | 34 | 7876223 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-041275 | 001-40315 | 231159144 | 34 | 587721 | 1 | 1 |
| 2023-07-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-043558 | 6669 | ||||||
| 2023-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-039541 | 5325 | ||||||
| 2023-06-23 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000014 | 001-40315 | 231039114 | 33 | 4500 | |||
| 2023-06-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-06-13 16:30:00 | 9999999995-23-001742 | 333-272421 | 231012870 | 33 | 1722 | ||
| 2023-06-09 | CORRESP | filename1.htm | 0001193125-23-164445 | 5595 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035585 | 5400 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035566 | 5408 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035565 | 5499 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035564 | 8496 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035563 | 8485 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035562 | 5452 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035560 | 8507 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035557 | 8450 | ||||||
| 2023-06-08 | UPLOAD | filename1.pdf | 0000000000-23-006159 | 40259 | ||||||
| 2023-06-07 | 8-K | 8-K | 5.07 | 0000950170-23-026807 | 001-40315 | 23998948 | 34 | 217049 | 1 | 1 |
| 2023-06-05 | S-3 | S-3 | 0001193125-23-160692 | 333-272421 | 23992509 | 33 | 206880 | |||
| 2023-05-30 | SC 13D/A | SC 13D/A | 0001193125-23-156675 | 005-92480 | 23977326 | 34 | 239574 | |||
| 2023-05-15 | SC 13D/A | SC 13D/A | 0001193125-23-145205 | 005-92480 | 23924335 | 34 | 66027 | |||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021234 | 001-40315 | 23911110 | 34 | 7044653 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-021217 | 001-40315 | 23910991 | 34 | 528205 | 1 | 1 |
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028533 | 5570 | ||||||
| 2023-05-09 | SC 13D/A | SC 13D/A | 0001193125-23-139466 | 005-92480 | 23902649 | 34 | 197114 | |||
| 2023-05-05 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-23-137165 | 001-40315 | 23894425 | 34 | 829419 | 1 | 1 |
| 2023-05-04 | 424B5 | 424B5 | 0001193125-23-136090 | 333-264616 | 23889965 | 33 | 623308 | |||
| 2023-05-03 | 424B5 | 424B5 | 0001193125-23-134428 | 333-264616 | 23884308 | 33 | 628005 | |||
| 2023-05-03 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-23-134386 | 001-40315 | 23883576 | 34 | 6546104 | 1 | 1 |
| 2023-04-26 | ARS | ARS | 0000950170-23-014812 | 001-40315 | 23849919 | 34 | 7398196 | |||
| 2023-04-26 | DEFA14A | DEFA14A | 0000950170-23-014803 | 001-40315 | 23849820 | 34 | 2094850 | |||
| 2023-04-26 | DEF 14A | DEF 14A | 0000950170-23-014792 | 001-40315 | 23849743 | 34 | 2473023 | |||
| 2023-03-27 | S-8 | S-8 | 0000950170-23-010044 | 333-270878 | 23765167 | 33 | 255490 | |||
| 2023-03-27 | 10-K | 10-K | 0000950170-23-009978 | 001-40315 | 23764521 | 34 | 16945627 | 1 | 1 | |
| 2023-03-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-009977 | 001-40315 | 23764493 | 34 | 794748 | 1 | 1 |
| 2023-03-14 | 8-K | 8-K | 8.01 | 0000950170-23-007709 | 001-40315 | 23729186 | 34 | 171650 | 1 | 1 |
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001193125-23-067520 | 001-40315 | 23723359 | 34 | 150216 | 1 | 1 |
| 2023-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-004092 | 001-40315 | 23516458 | 34 | 5692772 | 1 | 1 |
| 2022-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-061044 | 6367 | ||||||
| 2022-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-061038 | 9424 | ||||||
| 2022-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-061034 | 9371 | ||||||
| 2022-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-061032 | 10151 | ||||||
| 2022-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-061031 | 7176 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023250 | 001-40315 | 221369200 | 34 | 8448566 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023234 | 001-40315 | 221369137 | 34 | 817572 | 1 | 1 |
| 2022-09-30 | SC 13D/A | SC 13D/A | 0001193125-22-255621 | 005-92480 | 221284643 | 34 | 62103 | |||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-048534 | 5829 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-048532 | 11537 | ||||||
| 2022-08-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-048167 | 15675 | ||||||
| 2022-08-11 | SC 13D/A | SC 13D/A | 0001193125-22-218644 | 005-92480 | 221156646 | 34 | 228099 | |||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-016035 | 001-40315 | 221148272 | 34 | 7797139 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016015 | 001-40315 | 221148077 | 34 | 782328 | 1 | 1 |
| 2022-08-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-043994 | 5281 | ||||||
| 2022-08-02 | 3 | FORM 3 SUBMISSION | 0001209191-22-043993 | 5920 | ||||||
| 2022-08-02 | 8-K | 8-K | 5.02 | 0001193125-22-209391 | 001-40315 | 221126904 | 34 | 149929 | 1 | 1 |
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034225 | 5371 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034180 | 5469 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034178 | 5406 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034177 | 5375 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034176 | 5404 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034171 | 5428 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034175 | 5422 | ||||||
| 2022-06-02 | 8-K | 8-K | 5.07 | 0001558370-22-009679 | 001-40315 | 22991456 | 34 | 181952 | 1 | 1 |
| 2022-05-10 | 10-Q | 10-Q | 0001558370-22-008103 | 001-40315 | 22909783 | 34 | 5493845 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-008096 | 001-40315 | 22909642 | 34 | 421592 | 1 | 1 |
| 2022-05-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-05-09 16:00:00 | 9999999995-22-001381 | 333-264616 | 22907166 | 33 | 1721 | ||
| 2022-05-05 | CORRESP | filename1.htm | 0001193125-22-142273 | 6215 | ||||||
| 2022-05-04 | UPLOAD | filename1.pdf | 0000000000-22-004911 | 40194 | ||||||
| 2022-05-02 | S-3 | S-3 | 0001193125-22-136897 | 333-264616 | 22882727 | 33 | 1339435 | |||
| 2022-04-22 | DEFA14A | DEFA14A | 0001193125-22-115142 | 001-40315 | 22845648 | 34 | 566766 | |||
| 2022-04-22 | DEF 14A | DEF 14A | 0001193125-22-115089 | 001-40315 | 22845473 | 34 | 809735 | |||
| 2022-04-05 | 3 | FORM 3 SUBMISSION | 0001209191-22-023348 | 10521 | ||||||
| 2022-03-23 | S-8 | S-8 | 0001193125-22-082845 | 333-263799 | 22763751 | 33 | 103881 | |||
| 2022-03-23 | 10-K | 10-K | 0001558370-22-004158 | 001-40315 | 22763631 | 34 | 9699838 | 1 | 1 | |
| 2022-03-23 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-004156 | 001-40315 | 22763537 | 34 | 625801 | 1 | 1 |
| 2022-03-07 | 8-K | 8-K | 5.02 | 0001193125-22-068011 | 001-40315 | 22718439 | 34 | 152653 | 1 | 1 |
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016541 | 5504 | ||||||
| 2022-02-02 | 8-K | 8-K | 5.02 | 0001193125-22-025697 | 001-40315 | 22583636 | 34 | 150466 | 1 | 1 |
| 2022-01-27 | SC 13D/A | SC 13D/A | 0001193125-22-019678 | 005-92480 | 22562931 | 34 | 63605 | |||
| 2022-01-26 | SC 13G | SC 13G | 0001193125-22-018295 | 005-92480 | 22557981 | 34 | 54062 | |||
| 2022-01-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-004627 | 5325 | ||||||
| 2022-01-24 | 3 | FORM 3 SUBMISSION | 0001209191-22-004624 | 5976 | ||||||
| 2022-01-24 | 8-K | 8-K | 5.02 | 0001193125-22-016015 | 001-40315 | 22549362 | 34 | 151656 | 1 | 1 |
| 2021-12-27 | 8-K | 8-K | 5.02 | 0001193125-21-367001 | 001-40315 | 211520411 | 34 | 152188 | 1 | 1 |
| 2021-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-069448 | 7381 | ||||||
| 2021-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-069443 | 7336 | ||||||
| 2021-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-069439 | 7223 | ||||||
| 2021-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-069436 | 7397 | ||||||
| 2021-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-064587 | 7150 | ||||||
| 2021-11-12 | 10-Q | 10-Q | 0001558370-21-015674 | 001-40315 | 211400277 | 34 | 6856726 | 1 | 1 | |
| 2021-11-12 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-015672 | 001-40315 | 211400214 | 34 | 363892 | 1 | 1 |
| 2021-10-14 | 3 | FORM 3 SUBMISSION | 0001209191-21-060474 | 6026 | ||||||
| 2021-10-12 | 8-K | 8-K | 5.02 | 0001193125-21-296205 | 001-40315 | 211316661 | 34 | 156517 | 1 | 1 |
| 2021-08-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-053523 | 4980 | ||||||
| 2021-08-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-053522 | 4524 | ||||||
| 2021-08-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-053520 | 5000 | ||||||
| 2021-08-11 | 8-K | 8-K | 7.01,9.01 | 0001558370-21-011217 | 001-40315 | 211161928 | 34 | 3332081 | 1 | 1 |
| 2021-08-11 | 10-Q | 10-Q | 0001558370-21-011213 | 001-40315 | 211161897 | 34 | 5760317 | 1 | 1 | |
| 2021-08-11 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-011209 | 001-40315 | 211161835 | 34 | 403845 | 1 | 1 |
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046803 | 6187 | ||||||
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046802 | 5240 | ||||||
| 2021-07-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-046254 | 6786 | ||||||
| 2021-06-25 | 4 | xslF345X03/reneo_fm4jun232021.xml | 0000905718-21-000834 | 6705 | ||||||
| 2021-06-23 | 4 | xslF345X03/reneo_fm4jun212021.xml | 0000905718-21-000816 | 8931 | ||||||
| 2021-06-10 | 4 | xslF345X03/reneo_fm4jun82021.xml | 0000905718-21-000770 | 6704 | ||||||
| 2021-06-07 | 4 | xslF345X03/reneo_fm4jun32021.xml | 0000905718-21-000760 | 8930 | ||||||
| 2021-06-02 | 4 | xslF345X03/reneo_fm4may282021.xml | 0000905718-21-000744 | 6175 | ||||||
| 2021-05-28 | 4 | xslF345X03/reneo_fm4may262021.xml | 0000905718-21-000738 | 8932 | ||||||
| 2021-05-26 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-036015 | 4448 | ||||||
| 2021-05-20 | 10-Q | 10-Q | 0001558370-21-007568 | 001-40315 | 21942336 | 34 | 5018367 | 1 | 1 | |
| 2021-05-20 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-007566 | 001-40315 | 21942321 | 34 | 371812 | 1 | 1 |
| 2021-05-14 | 8-K | 8-K | 5.02 | 0001193125-21-161994 | 001-40315 | 21924528 | 34 | 17138 | ||
| 2021-04-23 | SC 13D | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D | 0001072613-21-000379 | 005-92480 | 21846805 | 34 | 360485 | |||
| 2021-04-20 | SC 13D | SC 13D | 0000905718-21-000606 | 005-92480 | 21837926 | 34 | 72519 | |||
| 2021-04-19 | SC 13D | SC 13D | 0001193125-21-120962 | 005-92480 | 21834015 | 34 | 310416 | |||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026862 | 23391 | ||||||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026826 | 14047 | ||||||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026823 | 10529 | ||||||
| 2021-04-15 | 3/A | FORM 3/A SUBMISSION | 0001209191-21-026820 | 4067 | ||||||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026817 | 8407 | ||||||
| 2021-04-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-026667 | 9437 | ||||||
| 2021-04-14 | SC 13D | SC 13D | 0001193125-21-116375 | 005-92480 | 21826146 | 34 | 121161 | |||
| 2021-04-13 | 4 | FORM 4 SUBMISSION | 0000899243-21-015634 | 19229 | ||||||
| 2021-04-13 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-21-114744 | 001-40315 | 21823434 | 34 | 168805 | ||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026343 | 5167 | ||||||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026340 | 5222 | ||||||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026339 | 5178 | ||||||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026338 | 5228 | ||||||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026337 | 5269 | ||||||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026336 | 5204 | ||||||
| 2021-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-026335 | 5214 | ||||||
| 2021-04-09 | 424B4 | 424B4 | 0001193125-21-111652 | 333-254534 | 21818288 | 33 | 3947894 | |||
| 2021-04-09 | S-8 | S-8 | 0001193125-21-110620 | 333-255140 | 21816309 | 33 | 357929 | |||
| 2021-04-08 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-001620 | 275639 | ||||||
| 2021-04-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-04-08 16:00:00 | 9999999995-21-001364 | 333-254534 | 21816394 | 33 | 1679 | ||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026130 | 5041 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026124 | 2842 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026123 | 16183 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0000899243-21-015406 | 12483 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026110 | 5939 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026107 | 11608 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026103 | 5907 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026099 | 8616 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026095 | 9027 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026094 | 7013 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026092 | 5892 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026090 | 12367 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026089 | 6985 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026088 | 6934 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026085 | 9699 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026082 | 7055 | ||||||
| 2021-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-026080 | 7972 | ||||||
| 2021-04-08 | CERT | 8A_Cert_RPHM.pdf | 0001354457-21-000457 | 001-40315 | 21814840 | 34 | 192819 | |||
| 2021-04-06 | 8-A12B | 8-A12B | 0001193125-21-107604 | 001-40315 | 21809386 | 34 | 13665 | |||
| 2021-04-06 | CORRESP | filename1.htm | 0001193125-21-107482 | 10311 | ||||||
| 2021-04-06 | CORRESP | filename1.htm | 0001193125-21-107478 | 8734 | ||||||
| 2021-04-05 | S-1/A | S-1/A | 0001193125-21-105697 | 333-254534 | 21803914 | 33 | 5875162 | |||
| 2021-03-22 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-001724 | 272600 | ||||||
| 2021-03-19 | CORRESP | filename1.htm | 0001193125-21-087749 | 37646 |
One latest value per concept from companyfacts (251 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 40.50M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 28.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 24,308.94 | 2026-04-24 | S-3 | 2026-04-24 | 0001193125-26-177093 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 24,308.94 | 2026-04-24 | S-3 | 2026-04-24 | 0001193125-26-177093 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 176.02M | 2026-04-24 | S-3 | 2026-04-24 | 0001193125-26-177093 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-04-24 | S-3 | 2026-04-24 | 0001193125-26-177093 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-04-24 | S-3 | 2026-04-24 | 0001193125-26-177093 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 6.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 88,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 4.66M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001193125-25-178981 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 1.22M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001558370-22-008103 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -30,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 420.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.49M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 138,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 9.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 142,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 6.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 14,790 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-05 | 0001193125-26-206345 | |
| us-gaap | Assets | Assets | USD | 167.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 165.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 89.56M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-20 | 0001558370-21-007568 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 2,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 11.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 11.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 11.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 11.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 11.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | USD | 65.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | USD | 57.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities | USD | 15.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other | USD | 690,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other | USD | 9.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets | USD | 553,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 11,000 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 151.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 163.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 151.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 92.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 3.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 210.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 3.34M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 3.34M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -48.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure | USD | 250,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 23.31M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 |
| us-gaap | DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax | USD | 0 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054452 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | -54,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | DeferredCompensationArrangementWithIndividualCompensationExpense | Deferred Compensation Arrangement with Individual, Compensation Expense | USD | 326,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | DeferredCompensationLiabilityClassifiedNoncurrent | Deferred Compensation Liability, Classified, Noncurrent | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 400,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 167,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0001558370-22-004158 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 7.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 123.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 36.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 58.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 800,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 91,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 89,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 6.11M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 19.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 1.89M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.42M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 840,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | USD | 35,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009978 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 123.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 126,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 9,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0001558370-22-004158 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 483,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 200,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 244,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | DepreciationExpenseOnReclassifiedAssets | Depreciation Expense on Reclassified Assets | USD | 244 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | Dividends | Dividends | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.27 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.82 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001558370-21-015674 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.27 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.454 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.001 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | 0.004 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0.018 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0001558370-22-004158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.225 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.034 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.025 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 2.80M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | -590,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0001558370-22-004158 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 57,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001558370-22-008103 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -300,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0001558370-22-004158 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -54,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -2,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 12.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009978 |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 400,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -78.13M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -77.39M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 744,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 27.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | -39,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -12.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 3,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 917,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -13.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -2.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 3.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -412,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 40,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 131,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009978 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 635,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 3.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | InterestIncomeOperating | Interest Income, Operating | USD | 3.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 907,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 255,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 34,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009978 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 34,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062910 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 270,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 262,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 120,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 117,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | Liabilities | Liabilities | USD | 9.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 167.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 8.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 0 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 140.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -11.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -36.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -48.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 51.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -51.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 148,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 214,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 300,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 790,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 251,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 539,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 440,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 661,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 379,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.092 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 617,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 409,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -17,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 12,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 48,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-23 | 0001558370-22-004158 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 3.11M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.55M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 183,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 4.40M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | PaymentsForRepurchaseOfPreferredStockAndPreferenceStock | Payments for Repurchase of Preferred Stock and Preference Stock | USD | 723,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 |
| us-gaap | PaymentsForRepurchaseOfPrivatePlacement | Payments for Repurchase of Private Placement | USD | 89,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 37,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 67.75M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 12.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 40,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 195.80M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | PreferredStockValueOutstanding | Preferred Stock, Value, Outstanding | USD | 53.80M | 2023-03-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 2.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 2.24M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 537,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 6.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 84.61M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009978 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 1.01M | 2023-01-01 | 2023-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054452 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 53.78M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 4.67M | 2023-01-01 | 2023-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0000950170-24-096411 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 25,000 | 2024-01-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269540 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 15.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ProceedsFromSaleOfInterestInCorporateUnit | Proceeds from Sale of Interest in Corporate Unit | USD | 57.74M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 26,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 203,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 2.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 414,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 39.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -262.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-036252 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 653,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269540 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 9.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 300,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001558370-21-015674 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.301 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 13,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 16.02 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 418,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001558370-21-011213 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 40,530 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 62,996 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 106,632 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 3.59 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001558370-21-015674 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 14,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 9.79 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 15,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269540 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 2.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 15.54 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 360,725 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 50.2 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 14.85 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 8.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 4.11 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | SharePrice | Share Price | USD/shares | 6.36 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-20 | 0001558370-21-007568 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 15.98M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 157.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.224 | 2021-04-05 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023250 | |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensation | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | shares | 70,663 | 2021-01-01 | 2021-03-31 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023250 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 129.82M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 203,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 65.50M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 173,000 | 2023-07-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123233 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 26,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001558370-22-008103 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104147 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 4.33M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 11.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038009 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 128,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 37.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 16.03M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001558370-21-015674 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 37.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447202 |